Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CSPS: Cilostazol for secondary stroke prevention
NCT00766545Phase 3Completed
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Apr 1992
- Primary completion
- Mar 1997
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cilostazol in cerebral infarction, sponsored by Otsuka Pharmaceutical Co., Ltd.. Started Apr 1992; status: completed.
02
Drugs
cilostazol
03
Conditions
cerebral infarction
Beyond the preview
Go deeper on NCT00766545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00766545.